日本血友病家系女性成员携带者状态的基因分析
本研究对69例日本男性血友病患者(48例血友病A,21例血友病B)及112名女性家系成员进行基因分析,基于杂合突变检测诊断携带者。血友病A和B女性家系成员中各有66%被确诊为携带者,仅10%基因确诊的血友病A携带者FVIII:C低于50 IU/dL,67%携带者FVIII/vWF比值低于0.9。
要点
- 基因分析是血友病女性携带者诊断的金标准。
- 血友病A携带者中仅10% FVIII:C低于50 IU/dL,FVIII:C不适用于携带者预测。
- 67%基因确诊的血友病A携带者FVIII/vWF比值低于0.9;半数血友病B携带者FIX:C低于60 IU/dL。
核心结论
- 基因分析是血友病女性携带者诊断的金标准,能良好识别基于家系信息和止血检测未发现的女性携带者。
- 本研究首次提供日本血友病女性携带者的遗传信息。
研究设计与样本
- 对69例男性血友病患者(48例血友病A,21例血友病B)和112名女性家系成员(80名来自50个血友病A家系,32名来自22个血友病B家系)进行基因分析。
- 采用DNA测序联合长聚合酶链反应检测倒位、多重连接依赖探针扩增检测大突变。
主要发现
- 72个血友病家系中,F8突变类型为倒位(42%)、错义突变(26%)和其他变异(32%);F9突变中74%为点突变。
- 112名女性家系成员中,血友病A携带者53/80(66%),血友病B携带者21/32(66%),基于杂合突变检测诊断。
- 基因确诊的血友病A携带者中仅10%检测到低FVIII:C水平(<50 IU/dL)。
- 基因确诊的血友病A携带者中67%观察到低FVIII/vWF比值(<0.9);基因确诊的血友病B携带者中半数有低FIX:C(<60 IU/dL)。
- 37例散发病例中32例母亲(86%)显示相关突变(血友病A 24/27 [89%],血友病B 8/10 [80%]),提示男性新发突变发生率低。
关键数值与推荐
- 血友病A携带者诊断:FVIII:C低于50 IU/dL仅见于10%基因确诊携带者。
- 血友病A携带者中FVIII/vWF比值低于0.9见于67%基因确诊携带者。
- 血友病B携带者中FIX:C低于60 IU/dL见于半数基因确诊携带者。
临床怎么用
- 基因分析应作为血友病女性携带者诊断的金标准,尤其当家系信息和止血检测结果不明确时。
- FVIII:C不适用于血友病A携带者预测;FVIII/vWF比值低于0.9可辅助提示血友病A携带状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic characteristics and genetic carrier diagnosis in Japanese hemophilia female carriers have not been evaluated. OBJECTIVES: To provide genetic information on Japanese hemophilia female carriers and demonstrate the advantages of genetic testing in carrier diagnosis. METHODS: DNA sequencing combined with long polymerase chain reaction for inversion and multiplex ligation-dependent probe amplification for large mutations. RESULTS: Genetic analysis was performed in 69 male hemophiliac patients (48 hemophilia A [HA] and 21 hemophilia B [HB]) and 112 female family members (FFM) (80 from 50 families with HA and 32 from 22 families with HB). In 72 hemophiliac families, the identified F8 mutations were inversion (42%), missense (26%), and other variations (32%), while 74% of F9 mutations were point mutations. Among the 112 FFM, 53/80 (66%) with HA and 21/32 (66%) with HB were diagnosed genetically as carriers based on detection of heterozygous mutations. Low factor VIII activity (FVIII:C) levels (<50 IU/dL) were detected in only 10% of gene-confirmed carriers, suggesting that FVIII:C is not suitable for HA carrier prediction. Low FVIII/von Willebrand factor ratio (<0.9) was observed in 67% of gene-confirmed carriers. Half of the gene-confirmed HB carriers had low FIX:C (<60 IU/dL). Importantly, 32 mothers of 37 sporadic cases (86%) (24/27 [89%] HA and 8/10 [80%] HB) showed the relevant mutations, suggesting low incidence of de novo mutations in males. CONCLUSIONS: This study is the first to provide genetic information on Japanese hemophilia female carriers. Gene analysis is the gold standard for carrier diagnosis as it well identifies undetected female carriers based on pedigree information and hemostatic measurements.
引用
- Shinozawa K, Amano K, Hagiwara T, et al. Genetic analysis of carrier status in female members of Japanese hemophilia families. J Thromb Haemost. 2021. PMID: 33760382. doi:10.1111/jth.15301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。